January 19, 2021
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Abby Adams
| Re: | Dyne Therapeutics, Inc. |
Registration Statement on Form S-1 (File No. 333-252194)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, please be advised that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others, prior to the requested effective time of the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement be accelerated to 4:00 p.m. Eastern Time, on January 20, 2021 or as soon thereafter as practicable.
[Signature page follows]
Very truly yours,
J.P. MORGAN SECURITIES LLC
JEFFERIES LLC
PIPER SANDLER & CO.
STIFEL, NICOLAUS & COMPANY, INCORPORATED
As representatives of the Underwriters
J.P. MORGAN SECURITIES LLC
| By: | /s/ David Ke | |
| Name: David Ke | ||
| Title: Executive Director |
JEFFERIES LLC
| By: | /s/ Dustin Tyner | |
| Name: Dustin Tyner | ||
| Title: Managing Director |
PIPER SANDLER & CO.
| By: | /s/ Chad E. Huber | |
| Name: Chad E. Huber | ||
| Title: Managing Director |
STIFEL, NICOLAUS & COMPANY, INCORPORATED
| By: | /s/ Nathan Thompson | |
| Name: Nathan Thompson | ||
| Title: Director |
[Signature Page to Dyne Therapeutics, Inc. Acceleration Request]